iBio
IBIO
34 hedge funds and large institutions have $10.4M invested in iBio in 2025 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 3 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 2
167% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 3
62% more capital invested
Capital invested by funds: $6.4M → $10.4M (+$4M)
13% more funds holding
Funds holding: 30 → 34 (+4)
2.36% less ownership
Funds ownership: 28.55% → 26.19% (-2.4%)
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$275K |
| 2 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$226K |
| 3 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$216K |
| 4 |
BlackRock
New York
|
+$144K |
| 5 |
State Street
Boston,
Massachusetts
|
+$131K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $72 | -$6.23K | -1,603 | -99% |
|
|
SWA
27
SOA Wealth Advisors
New York
| $52 | – | – | – |
|
|
AWM
28
Activest Wealth Management
Aventure,
Florida
| $16 | – | – | – |
|
|
CHC
29
City Holding Co
Charleston,
West Virginia
| $16 | – | – | – |
|
30
BNP Paribas Financial Markets
Paris,
France
| $8 | – | – | – |
|
31
JP Morgan Chase
New York
| $8 | – | – | – |
|
|
FGAM
32
Financial Gravity Asset Management
Lakeway,
Texas
| $8 | +$8 | +2 | New |
|
|
SPIA
33
Steward Partners Investment Advisory
New York
| $4 | – | – | – |
|
34
Wells Fargo
San Francisco,
California
| $4 | – | – | – |
|
|
ACM
35
ADAR1 Capital Management
Austin,
Texas
| – | -$1.02M | -415,606 | Closed |
|
36
Citigroup
New York
| – | -$103 | -42 | Closed |
|
37
Fidelity Investments
Boston,
Massachusetts
| – | -$2 | -1 | Closed |
|
IBIO Hedge Fund Activity: Q1 2025 in Review
34 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in iBio (IBIO) for Q1 2025, worth a combined $10.4M — up 62% from $6.4M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new IBIO positions and 3 closed out — a net gain of 5 holders — while 10 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $275K. The largest seller was ADAR1 Capital Management, exiting entirely with an estimated $1.02M sold.
- 34 institutional investors held iBio (IBIO) as of Q1 2025, up from 30 in Q4 2024.
- Funds reported $10.4M of iBio stock for Q1 2025, up 62% quarter-over-quarter.
- 8 funds opened new iBio positions in Q1 2025 and 3 closed out, a net change of +5 holders.
- The largest iBio buyer in Q1 2025 was Vanguard Group, an estimated $275K added.
- The largest iBio seller in Q1 2025 was ADAR1 Capital Management, an estimated $1.02M sold.
Based on aggregated 13F filings for Q1 2025.